Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ

NCT00438659 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

176

Enrollment

NETWORK

Sponsor class

Conditions

Breast Cancer
Dermatologic Complications
Radiation Toxicity
Skin Reactions Secondary to Radiation Therapy

Interventions

DRUG: mometasone furoate
OTHER: placebo

Sponsor

North Central Cancer Treatment Group

Collaborators

[object Object]